Phastar’s Clinical Intelligence Portal Shortlisted as Finalist in 2024 Citeline Award
March 25, 2024 – Clinical Trials – Phastar, awards, clinical trials
High quality data visualisation and advanced recruitment forecasting app shapes success story in Best Sponsor Facing Initiative
25 March 2024 — London, UK, and North Carolina, US — Phastar, a global specialist biometrics contract research organisation (CRO), has been selected as finalist for the Best Sponsor-facing Technology Initiative at the Citeline Awards 2024. Phastar were recognised for the launch of their Clinical Intelligence Portal, and notably the comprehensive recruitment forecasting app within that suite. The Citeline Award winners will be announced at a gala dinner in Boston, US, on 8 May.
For over a decade, Phastar’s Clinical analytics expertise and solutions have supported end-to-end clinical trial development by enabling fast, accurate assessment of vast volumes of operational, clinical and safety data, quickly identifying trends, outliers and meaningful insights and driving more efficient processes and improving decision-making.
The launch in 2023 of Phastar’s future proof Clinical Intelligence Portal saw a significant update in approach, putting users in the driving seat and offering next generation data visualisations and bespoke, customisable dashboards for tailored reporting. This seamless integration of high-quality data analysis and visualisation with real-time data access enables timely decision-making and rapid response to emerging signals. The portal provides clients access to a suite of advanced tools that enhance insight gathering, with the latest addition being inclusion of a comprehensive recruitment forecasting app. A winning case study proved success with a sponsor where clinical trials frequently failed to meet the target of administering the first treatment to the last participant within the planned timeframe from an inability to swiftly identify bottlenecks within their studies and formulate effective solutions.
Graham Clark, CEO at Phastar, commented, “We are delighted to be named as a finalist for the Best Sponsor-facing Technology Initiative at the Citeline Awards 2024. Our Clinical Intelligence Portal, featuring a ground-breaking recruitment forecasting app, exemplifies our dedication to empowering our clients with actionable insights, fostering efficiency, reducing costs and accelerating clinical trial development. This recognition stands as a testament to the ingenuity of our team at Phastar and reaffirms our commitment to driving innovation in clinical analytics and helping to improve patient outcomes.”
About Phastar
Phastar is an award winning, global, specialist biometrics CRO offering leading data management, data science, statistical consulting and clinical trial reporting services by providing expert consultants and managing and delivering in-house projects, FSP-style arrangements and preferred partnerships. Phastar currently has 15 offices worldwide with plans to open additional locations in the future to serve prospective and existing clients. Our number one priority is ensuring on time, quality work: every project undertaken is supervised on methodology and utilises internal processes designed to guarantee optimal quality, inspired by 4,000 years accumulated technical experience across the company. Visit: www.phastar.com.
